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Rationale for this work
 New NHS High Energy Proton Beam Therapy (PBT) facility opening 
in Manchester autumn 2018
 Within the outline business case, identified that patients with 
paranasal cancer would be one of a number of cancers which 
would benefit from PBT
 Anticipate potential improvement in local control and reduction 
in complications
 Although advantageous with respect to normal tissue toxicity, the 
Increased conformity from PBT is vulnerable to considerable error 
as a result of uncertainties in beam range
 PBT more sensitive to anatomical changes than with photon 
therapy
 MSc Dissertation of David Kirk 
(A Superintendent Radiographer 
(RTT) for the Christie PBT facility)
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Aims and Objectives
 Examine in a systematic way the evidence base for 
the various known range uncertainties which might 
affect paranasal cancer treatments for the new UK 
PBT service
 Explore the extent of the uncertainty
 Extract the effectiveness of proposed corrective actions
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Methods used
 PubMed database used for key searches related to 
range uncertainty in PBT in general and for PBT for 
paranasal sinus treatments in particular
 Initial search in April/May 2015 and monthly thereafter; 
using appropriate keywords, inclusion and exclusion 
criteria
 Follow-up search in Feb 2018
 Papers were filtered and appraised critically for 
relevance and robustness
 From an initial search result of over 220 papers…
 97 papers were reviewed for range uncertainty (16 in Feb 
2018)
 7 papers specific to paranasal cancer (8 in Feb 2018)
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Main Results Found
 Patients should ideally undergo prep/planning without a 
fluid filled sinus
 Adequate drainage, if possible, provided surgically
beforehand
 Status monitored throughout treatment – volumetric imaging 
(CBCT) or verification CT
 Impact of weight change can be less problematic for well-
optimised plans
 Distal end of SOBP never against an OAR if significant weight 
change anticipated
 Variations in RBE across peak are of concern; of current
debate – tomorrow’s teaching lecture!
 Std value of 1.1; literature 1.07 – 1.18 for mid-SOBP
 Margin of uncertainty should be examined for each 
site/individual cases
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Clinical Impact
 Establish clinical protocols which are informed by..
 Experience from current, global PBT centres and their 
treatment for these cancers
 Evidence base and review for Paranasal cancer patients 
treated with PBT
 Potentially provide a platform for more effective 
treatment with this cohort of patients and…..
 Establish foundation for further development of the
clinical techniques – e.g. for Intensity Modulated
Proton Therapy
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Future directions
 The NHS UK PBT Service has opted for the Varian 
ProBeam system and Eclipse TPS; due for clinical 
implementation in 2018 (Manchester) and 2020 
(London)
 This work is helping to inform the set-up and
establishment of clinical protocols for the new service
 Part of the training and education for all staff involved 
with PBT, especially Radiographers (Radiation 
Therapists)
 Especially of note is the development of an
understanding and knowledge base for the critical 
differences between photon and proton therapy
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Any questions?
Thanks for your attention!
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